(NYSE: BAK) Braskem Sa's forecast annual revenue growth rate of 12.22% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 0.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.64%.
Braskem Sa's revenue in 2025 is $13,439,409,722.On average, 2 Wall Street analysts forecast BAK's revenue for 2025 to be $12,023,285,264,390, with the lowest BAK revenue forecast at $11,513,363,231,490, and the highest BAK revenue forecast at $12,533,207,297,291.
In 2026, BAK is forecast to generate $12,721,982,126,343 in revenue, with the lowest revenue forecast at $12,480,551,719,855 and the highest revenue forecast at $12,963,412,532,831.